Complementary approaches to study NKT cells in cancer.

Berzofsky, Jay A; Olkhanud, Purevdorj B; Terabe, Masaki

Berzofsky, Jay A; Olkhanud, Purevdorj B; Terabe, Masaki.

Afiliação

Berzofsky JA; Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States. Electronic address: berzofsj@mail.nih.gov.
Olkhanud PB; Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Terabe M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Methods Enzymol ; 631: 371-389, 2020.

Article em En | MEDLINE | ID: mdl-31948558

Assuntos

Antígenos CD1d/imunologia; Testes Imunológicos de Citotoxicidade/métodos; Imunoterapia; Células T Matadoras Naturais/imunologia; Neoplasias/imunologia; Animais; Antígenos CD1d/genética; Camundongos; Camundongos Knockout; Camundongos Transgênicos; Neoplasias/terapia

Palavras-chave

CD1d; Ceramides; Glycolipid antigens; Immunoregulation; NKT cells; Tumor immunity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes Imunológicos de Citotoxicidade / Células T Matadoras Naturais / Antígenos CD1d / Imunoterapia / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google